As tech titans back startups looking to create genetically modified babies, Claudia Cockerell asks: is it about stopping disease, or something darker?
The first wave of Commissioner’s National Priority Vouchers signals a fundamental shift in FDA competitiveness, rewarding companies that pair breakthrough science with affordability commitments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback